生育治疗与多发脑膜瘤及更年轻诊断年龄相关
该回顾性研究(2015-2018年)纳入206例女性脑膜瘤患者,其中26例(12.6%)有生育治疗史。有生育治疗史者平均诊断年龄显著更年轻(51.8岁 vs 57.3岁,p=0.0135),多因素分析中多发脑膜瘤(OR 4.97,95%CI 1.4-18.1,p=0.0154)和凸面/大脑镰脑膜瘤(OR 4.45,95%CI 1.7-11.5,p=0.0021)风险更高。
要点
- 206例女性脑膜瘤中26例(12.6%)有生育治疗史。
- 有生育治疗史者平均诊断年龄51.8岁 vs 57.3岁(p=0.0135)。
- 多因素分析示多发脑膜瘤OR 4.97、凸面/大脑镰脑膜瘤OR 4.45。
核心结论
- 该队列中有生育治疗史的女性脑膜瘤患者更年轻,且更易为多发及凸面/大脑镰脑膜瘤,提示评估脑膜瘤患者时应采集雌激素/孕激素暴露史。
研究设计与样本
- 回顾性研究,纳入2015-2018年206例女性脑膜瘤患者,比较有与无生育治疗史者。
主要发现
- 26例(12.6%)有生育治疗史;辅助生殖技术包括体外受精(50.0%)、克罗米芬伴或不伴宫内授精(34.6%)、未指明(19.2%)。
- 中位随访1.8年;肿瘤WHO I级78.6%、II级21.4%。
- 有生育治疗史者平均诊断年龄51.8岁 vs 57.3岁(p=0.0135,双侧T检验)。
- 多因素分析:多发脑膜瘤OR 4.97(95%CI 1.4-18.1,p=0.0154),凸面/大脑镰脑膜瘤OR 4.45(95%CI 1.7-11.5,p=0.0021)。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Meningiomas are more common in females and 70-80% express the progesterone receptor, raising the possibility that high-dose exogenous estrogen/progesterone exposure, such as occurs during fertility treatments, may increase the risk of developing a meningioma. The goal of this study was to report the incidence of prior fertility treatment in a consecutive series of female meningioma patients. METHODS: A retrospective review (2015-2018) was performed of female patients with meningioma, and those with prior fertility treatment were compared to those without fertility treatment using standard statistical methods. RESULTS: Of 206 female patients with meningioma, 26 (12.6%) had a history of fertility treatments. Patients underwent various forms of assisted reproductive technology including: in vitro fertilization (50.0%), clomiphene with or without intrauterine insemination (34.6%), and unspecified (19.2%). Median follow up was 1.8 years. Tumors were WHO grade I (78.6%) or grade II (21.4%). Patients who underwent fertility treatments presented at significantly younger mean age compared to those who had not (51.8 vs. 57.3 years, p = 0.0135, 2-tailed T-test), and on multivariate analysis were more likely to have multiple meningiomas (OR 4.97, 95% CI 1.4-18.1, p = 0.0154) and convexity/falx meningiomas (OR 4.45, 95% CI 1.7-11.5, p = 0.0021). CONCLUSIONS: Patients in this cohort with a history of fertility treatment were more likely to present at a younger age and have multiple and convexity/falx meningiomas, emphasizing the importance of taking estrogen/progesterone exposure history when evaluating patients with meningioma. Future clinical studies at other centers in larger populations and laboratory investigations are needed to determine the role of fertility treatment in meningioma development.
引用
- Shahin MN, Magill ST, Dalle Ore CL, et al. Fertility treatment is associated with multiple meningiomas and younger age at diagnosis. J Neurooncol. 2019. PMID: 30868355. doi:10.1007/s11060-019-03147-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。